Published in Nat Commun on July 04, 2016
In vivo models in breast cancer research: progress, challenges and future directions. Dis Model Mech (2017) 0.78
Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. Carcinogenesis (2016) 0.77
Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer. J Mammary Gland Biol Neoplasia (2017) 0.75
Landscape of genomic alterations in pituitary adenomas. Clin Cancer Res (2016) 0.75
Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet (2017) 0.75
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell (2006) 27.36
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol (2007) 10.49
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol (2011) 9.60
Lessons from the cancer genome. Cell (2013) 8.12
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat (2009) 7.91
Pan-cancer patterns of somatic copy number alteration. Nat Genet (2013) 7.73
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet (2006) 7.16
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09
Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res (2000) 3.24
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature (2014) 2.85
Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc Natl Acad Sci U S A (2004) 2.81
Gene expression analysis identifies global gene dosage sensitivity in cancer. Nat Genet (2015) 2.68
CGH-Explorer: a program for analysis of array-CGH data. Bioinformatics (2004) 2.65
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov (2014) 2.51
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell (2015) 2.39
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell (2009) 2.09
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A (2011) 2.01
Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma. Nat Med (2015) 1.80
Mouse models of breast cancer metastasis. Breast Cancer Res (2006) 1.62
Loss of the 14-3-3σ tumor suppressor is a critical event in ErbB2-mediated tumor progression. Cancer Discov (2011) 1.57
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature (2014) 1.57
Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers. Cancer Res (2006) 1.53
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell (2007) 1.53
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J Exp Clin Cancer Res (2012) 1.48
Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Proc Natl Acad Sci U S A (2009) 1.26
A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice. Genes Chromosomes Cancer (1999) 1.26
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity. Nature (2015) 1.22
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer. Nat Genet (2014) 1.16
PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Oncogene (2010) 1.12
Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K. EMBO Mol Med (2014) 1.11
The role of epigenetic inactivation of 14-3-3sigma in human cancer. Cell Res (2005) 1.11
Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nat Protoc (2013) 1.11
A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer. Breast Cancer Res (2014) 0.97
Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers. Cancer Biol Ther (2006) 0.92
Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nat Med (2015) 0.89
14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion. Proc Natl Acad Sci U S A (2013) 0.89
Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches. Curr Opin Genet Dev (2012) 0.88
Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer. Breast Cancer Res Treat (2015) 0.88
BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer. Breast Dis (2010) 0.85
14-3-3 sigma and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming growth factor-beta 1. Mol Cells (2010) 0.85
Genetically engineered mice as experimental tools to dissect the critical events in breast cancer. Adv Cancer Res (2014) 0.84
From chromosomal abnormalities to the identification of target genes in mouse models of breast cancer. Cancer Genet (2014) 0.78
Survinin expression in patients with breast cancer during chemotherapy. Tumour Biol (2014) 0.77
14-3-3 σ is a new target up-regulated by transforming growth factor-β1 through a Smad3-dependent mechanism. Biochem Biophys Res Commun (2013) 0.77
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine. Cancer Res (2015) 0.76
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun (2016) 1.94
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature (2014) 1.88
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet (2016) 1.74
The effect of host genetics on the gut microbiome. Nat Genet (2016) 1.00
Disease variants alter transcription factor levels and methylation of their binding sites. Nat Genet (2016) 0.87
Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes. Eur J Hum Genet (2015) 0.77
CNV-association meta-analysis in 191,161 European adults reveals new loci associated with anthropometric traits. Nat Commun (2017) 0.75
Evidence for mitochondrial genetic control of autosomal gene expression. Hum Mol Genet (2016) 0.75
A characterization of cis- and trans-heritability of RNA-Seq-based gene expression. Eur J Hum Genet (2019) 0.75
Shared genetic variants suggest common pathways in allergy and autoimmune diseases. J Allergy Clin Immunol (2017) 0.75